Follicle-stimulating hormone promotes RANK expression on human monocytes
- Joseph G. Cannon(corresponding author),
- Barbara Kraj,
- Gloria Sloan
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>Elevated serum concentrations of follicle-stimulating hormone (FSH) are associated with diminished bone density in women, beginning years before menopause and the decline in estradiol. We hypothesized that FSH promotes development of myeloid cells toward the bone-resorbing osteoclast phenotype. This was tested by isolating peripheral blood mononuclear cells from nine healthy adults, incubating them in the presence of FSH at three different concentrations spanning the physiological range, and then measuring the expression of receptor activator for NF-κB (RANK, a surface marker for osteoclasts) on CD14<sup>+</sup> cells by flow cytometry. In the absence of FSH, 3.3±0.5% of the cells expressed high levels of the receptor (RANK<sup>high</sup>). Increasing concentrations of FSH caused a biphasic dose-response, with a maximal (1.5-fold) increase in RANK<sup>high</sup> cells achieved with 50mIU/ml FSH (P=0.02). Cytokines that influence development of osteoclasts were also measured in culture supernatants: macrophage colony stimulating factor (M-CSF), osteoprotegerin (OPG) and tumor necrosis factor-α (TNFα) concentrations were not significantly influenced by FSH, whereas RANK-ligand was undetectable. This study supports the concept that the elevated circulating concentrations of FSH during perimenopause may contribute to the increased rate of bone loss by promoting the development of osteoclast precursor cells.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 141-144 (4 pages)Journal (Volume, Issue Number)
Cytokine (Volume 53, Issue 2)Publication milestones
- Published - 02/2011
Publication status
Published - 02/2011
ISSN
1043-4666Publication IDs
- Scopus: 78651078968
- PubMed: 21159522
Publication metrics
Metrics
SciVal
FWCI
0.92
SciVal
Author count
3
SciVal
citations
49
SciVal
Paper percentile
91
SciVal
Top percentile
10
Fractional count
3
Fractional count
1
Fractional count
3
Fractional count
1
PlumX, opens in new tab
Citation count
82
Captures
33
Usage
480
Funding Details
This work was supported by AG027714 from the National Institutes of Health .
FundersFunding number
NIH
-NIA
R21AG027714
